Prime Medicine, Inc. PRME
2.90
(0.17)
(5.54%)
as of 25 Sep
- Market cap
- $609.4M
- P/E
- 0.0×
Follow PRME
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | 0.00 | — |
P/S ratio |
111.44 | 0.00 | — | — | — | 0.00 | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | 0.00 | — |
P/Operating CF |
(13.86) | 21.32 | — | — | — | (11.35) | — |
P/B ratio |
4.27 | 2.26 | — | — | — | 0.00 | — |
Price to Tangible BV |
4.27 | 2.26 | — | — | — | 0.00 | — |
EV/Sales |
73.08 | 0.00 | — | — | — | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | — | — | — | 0.00 | — |
EV/Operating CF |
(2.08) | (1.27) | — | — | — | (1.71) | — |
EV/FCF |
(2.03) | (1.20) | — | — | — | (1.55) | — |
Quick Ratio |
4.74 | 5.02 | 2.16 | 11.00 | 4.65 | 2.74 | — |
Current Ratio |
4.84 | 5.58 | 2.53 | 11.10 | 4.67 | 2.75 | — |
Net Debt/EBITDA |
0.88 | 0.95 | 0.60 | 2.57 | 3.24 | 59.99 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.81 | 0.63 | 0.83 | 0.93 | 0.19 | 1.10 | 0.48 |
Capex/Depreciation |
(0.84) | (2.40) | (7.01) | (8.15) | (3.23) | (14.86) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (146.81%) | (136.88%) | (88.19%) | (177.48%) | 239.27% | 0.00% | 0.00% | |
| (62.83%) | (79.73%) | (71.51%) | (42.89%) | (121.99%) | 0.00% | 0.00% | |
ROIC |
0.00% | 0.00% | (1,122.17%) | (325.92%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(122.34%) | (98.77%) | (181.42%) | (49.15%) | (84.64%) | (14.63%) | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | — | — | — | 0.00 | — |
Research and Development Expense of Revenue |
3,467.96% | 5,205.80% | 0.00% | 0.00% | 0.00% | 57.20% | 0.00% |
Selling, General and Administrative Expense of Revenue |
1,130.09% | 1,681.56% | 0.00% | 0.00% | 0.00% | 60.69% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Share Based Compensation of Revenue |
631.87% | 873.89% | 0.00% | 0.00% | 0.00% | 7.50% | — |
Graham Net Nets |
(0.08) | 0.20 | — | — | — | 0.31 | — |
Graham Number |
0.00 | 0.00 | — | — | — | 0.00 | — |
Earnings Yield |
(39.29%) | (56.51%) | — | — | — | (33.31%) | — |
Free Cash Flow Yield |
(32.37%) | (37.58%) | — | — | — | (36.87%) | — |
Revenue per Share |
0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 1.97 | 0.00 |
Operating CF per Share |
(1.09) | (1.04) | (1.82) | (3.89) | (2.63) | (2.10) | (0.01) |
Capex per Share |
(0.03) | (0.06) | (0.10) | (0.47) | (0.32) | (0.24) | 0.00 |
Free Cash Flow per Share |
(1.12) | (1.10) | (1.91) | (4.36) | (2.95) | (2.34) | (0.01) |
Cash per Share |
1.19 | 1.61 | 1.34 | 8.67 | 20.78 | 20.20 | 0.00 |
Shareholders Equity per Share |
0.81 | 1.29 | 1.46 | 9.33 | 18.47 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.81 | 1.29 | 1.46 | 9.33 | 18.47 | 0.00 | 0.00 |
Free Cash Flow |
(167.09) | (130.16) | (174.14) | (147.92) | (38.23) | (6.18) | (1.33) |
Working Capital |
143.85 | 173.93 | 86.55 | 269.90 | 212.60 | 33.96 | — |
Capital Expenditures |
(4.53) | (7.29) | (8.72) | (16.09) | (4.15) | (0.64) | — |
Net Current Asset Value |
(40.57) | 67.53 | 82.20 | 252.57 | 208.28 | 53.40 | — |
EV/EBIT |
0.00 | 0.00 | — | — | — | 0.00 | — |
Capex to Sales |
0.98 | 2.45 | 0.00 | 0.00 | 0.00 | 0.12 | — |
Net Profit Margin |
(4,342.44%) | (6,566.61%) | 0.00% | 0.00% | 0.00% | (97.02%) | 0.00% |
Price to Operating Income |
0.00 | 0.00 | — | — | — | 0.00 | — |
| Other line items | |||||||
Depreciation/Fixed assets |
0.26 | 0.12 | 0.05 | 0.10 | 0.26 | 0.07 | — |
Cash ROIC |
(61.34%) | (42.86%) | (73.83%) | (24.72%) | (7.66%) | (11.51%) | 0.00% |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | — | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — |
Average Payables |
10.12 | 15.44 | 11.93 | 2.88 | 0.84 | — | — |
Average Assets |
320.12 | 245.68 | 277.08 | 331.09 | 150.93 | — | — |
Average Common Equity |
137.01 | 143.11 | 224.67 | 80.02 | (76.95) | — | — |
Columns are period end dates